Aryl[ a ]pyrrolo[3,4- c ]carbazoles as selective cyclin D1-CDK4 inhibitors-Reference-Cited by-同舟云学术

Aryl[ a ]pyrrolo[3,4- c ]carbazoles as selective cyclin D1-CDK4 inhibitors

Published:2003-11 Issue:21 Volume:13 Page:3835-3839
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Sanchez-Martinez Concha,Shih Chuan,Faul Margaret M.,Zhu Guoxin,Paal Michael,Somoza Carmen,Li Tiechao,Kumrich Christine A.,Winneroski Leonard L.,Xun Zhou,Brooks Harold B.,Patel Bharvin K.R.,Schultz Richard M.,DeHahn Tammy B.,Spencer Charles D.,Watkins Scott A.,Considine Eileen,Dempsey Jack A.,Ogg Catherine A.,Campbell Robert M.,Anderson Bryan A.,Wagner Jill

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference41 articles.

1. Cyclins and cyclin-dependent kinases: take your partners

2. CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors

3. Cyclins and cancer

4. A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress in CDK4/6 Inhibitors and PROTACs;Molecules;2023-12-13

2. Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells;Molecules;2022-11-17

3. High-throughput virtual screening followed by in vitro investigation to identify new lead inhibitors of Cyclin Dependent Kinase 4;Journal of Molecular Graphics and Modelling;2021-12

4. Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs;Acta Pharmaceutica Sinica B;2021-01

5. How selective are clinical CDK4/6 inhibitors?;Medicinal Research Reviews;2020-12-10